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ABSTRACT 
The effects of microbial metabolites on host 
physiology 
Ava Parséus 
Department of Molecular and Clinical Medicine, Institute of Medicine 
Sahlgrenska Academy at University of Gothenburg, Sweden 
In recent years it has become increasingly clear that the gut microbial community, the microbiota, has 
a vast impact on obesity, insulin signaling and glucose homeostasis. More specifically, there are 
microbiota-derived metabolites that are known to possess important functions, both locally in the gut, 
but also on a systemic level. However, the impact they have on host physiology in terms of 
contributors to diet-induced obesity (DIO), effects on insulin signaling and obesity-related 
dysfunctions has been poorly studied. In this thesis the impact on host physiology of the microbial 
metabolites short-chain fatty acids (SCFA) and bile acids were studied in more detail. As study models 
conventionally raised mice (CONV-R), mice colonized at birth with the microorganisms present in 
their environment, and germ free (GF) mice, mice deprived of any microorganism and hence 
microbiota, were used.   
In paper I, we used as study models wild-type mice and a whole-body knockout of the natural bile 
acid receptor farnesoid X receptor (FXR) on a CONV-R and GF background. These mice were treated 
with high-fat diet and the results shows that the gut microbiota promotes DIO via FXR signaling, and 
more importantly, that the altered bile acid profiles and hence FXR signaling affects DIO. Also, our 
findings suggest that the genotype is also involved in shaping the microbial composition.  
In paper II, we observed a prominent difference between GF and CONV-R mice where the former 
had significantly higher serum levels of the incretin hormone glucagon-like peptide-1 (GLP-1) and 
increased colonic proglucagon expression; the gene GLP-1 is transcribed from. We demonstrated that 
the increased GLP-1 levels in GF mice are regulated via energy supply, namely the SCFAs. More 
importantly, elevated GLP-1 levels slowed intestinal transit. 
From paper I we conclude that the microbiotas’ impact on shaping the bile acid profile has significant 
impact on DIO and leads to obesity-related dysfunctions. In paper II we conclude that GF mice have 
slower transit time to allow sufficient energy-and nutrient absorption 
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